Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure

Growth Hormone and IGF Research

Volumn 19, Issue 6, 2009, Pages 486-490

  Andreassen, Mikkel ^a   Kistorp, Caroline ^a   Raymond, Ilan ^a   Hildebrandt, Per ^a   Gustafsson, Finn ^a   Kristensen, Lars Østergaard ^a   Faber, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chronic heart failure; Growth hormone system; IGF I; Mortality

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; SOMATOMEDIN C;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

AGED; CASE-CONTROL STUDIES; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 71749100859     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.03.003     Document Type: Article

References (25)

1. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm. IGF Res. 13 (2003) 113-170
2. Opgaard O.S., and Wang P.H. IGF-I is a matter of heart. Growth Horm. IGF Res. 15 (2005) 89-94
3. Jankowska E.A., Biel B., Majda J., Szklarska A., Lopuszanska M., Medras M., Anker S.D., Banasiak W., Poole-Wilson P.A., and Ponikowski P. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 114 (2006) 1829-1837
4. Broglio F., Fubini A., Morello M., Arvat E., Aimaretti G., Gianotti L., Boghen M.F., Deghenghi R., Mangiardi L., and Ghigo E. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin. Endocrinol. (Oxf) 50 (1999) 417-430
5. Duerr R.L., Huang S., Miraliakbar H.R., Clark R., Chien K.R., and Ross Jr. J. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 95 (1995) 619-627
6. Lee W.L., Chen J.W., Ting C.T., Ishiwata T., Lin S.J., Korc M., and Wang P.H. Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy. Endocrinology 140 (1999) 4831-4840
7. Schulze P.C., and Spate U. Insulin-like growth factor-1 and muscle wasting in chronic heart failure. Int. J. Biochem. Cell Biol. 37 (2005) 2023-2035
8. Hambrecht R., Schulze P.C., Gielen S., Linke A., Mobius-Winkler S., Yu J., Kratzsch J.J., Baldauf G., Busse M.W., Schubert A., Adams V., and Schuler G. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J. Am. Coll. Cardiol. 39 (2002) 1175-1181
9. Le C.P., Hittinger L., Chanson P., Montagne O., Quin-Mavier I., and Maison P. Cardiac effects of growth hormone treatment in chronic heart failure: a meta-analysis. J. Clin. Endocrinol. Metab. 92 (2007) 180-185
10. Petretta M., Colao A., Sardu C., Scopacasa F., Marzullo P., Pivonello R., Fontanella L., de Caterina M., de Simone A., and Bonaduce D. NT-proBNP, IGF-I and survival in patients with chronic heart failure. Growth Horm. IGF Res. 17 (2007) 288-296
11. Hassfeld S., Eichhorn C., Stehr K., Naegele H., Geier C., Steeg M., Ranke M.B., Oezcelik C., and Osterziel K.J. Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy. Heart 93 (2007) 359-360
12. Galatius S., Gustafsson F., Nielsen P.H., Atar D., and Hildebrandt P.R. An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am. Heart J. 144 (2002) E2
13. Raymond I., Pedersen F., Busch-Sorensen M., Green A., and Hildebrandt P. The Frederiksberg heart failure study: rationale, design, methodology with special emphasis on the sampling procedure for the study population and its comparison to the background population. Heart Drug 2 (2002) 167-174
14. Yu H., Mistry J., Nicar M.J., Khosravi M.J., Diamandis A., van Doorn J., and Juul A. Insulin-like growth factor (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6 and ALS) in blood circulation. J. Clin. Lab. Anal. 13 (1999) 166-172
15. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
16. Ranke M.B., Osterziel K.J., Schweizer R., Schuett B., Weber K., Robbel P., Vornwald A., Blumenstock G., and Elmlinger M.W. Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays. Clin. Chem. Lab. Med. 41 (2003) 1329-1334
17. Anwar A., Gaspoz J.M., Pampallona S., Zahid A.A., Sigaud P., Pichard C., Brink M., and Delafontaine P. Effect of congestive heart failure on the insulin-like growth factor-1 system. Am. J. Cardiol. 90 (2002) 1402-1405
18. Roth J., Glick S.M., Yalow R.S., and Berson S.A. Secretion of human growth hormone: physiologic and experimental modification. Metabolism 12 (1963) 577-579
19. Osterziel K.J., Ranke M.B., Strohm O., and Dietz R. The somatotrophic system in patients with dilated cardiomyopathy: relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function. Clin. Endocrinol. (Oxf) 53 (2000) 61-68
20. Al-Obaidi M.K., Hon J.K., Stubbs P.J., Barnes J., Amersey R.A., Dahdal M., Laycock J.F., Noble M.I., and Aghband-Zadeh J. Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failure. Am. Heart J. 142 (2001) E10
21. Maggio M., Ceda G.P., Lauretani F., Pahor M., Bandinelli S., Najjar S.S., Ling S.M., Basaria S., Ruggiero C., Valenti G., and Ferrucci L. Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). Am. J. Cardiol. 97 (2006) 1525-1529
22. Corbalan R., Acevedo M., Godoy I., Jalil J., Campusano C., and Klassen J. Enalapril restores depressed circulating insulin-like growth factor 1 in patients with chronic heart failure. J. Card. Fail. 4 (1998) 115-119
23. Maison P., and Chanson P. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation 108 (2003) 2648-2652
24. Takala J., Ruokonen E., Webster N.R., Nielsen M.S., Zandstra D.F., Vundelinckx G., and Hinds C.J. Increased mortality associated with growth hormone treatment in critically ill adults. N. Engl. J. Med. 341 (1999) 785-792
25. Liu H., Bravata D.M., Olkin I., Nayak S., Roberts B., Garber A.M., and Hoffman A.R. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann. Int. Med. 146 (2007) 104-115